Alterity Therapeutics Limited (PRNAF)

USD 0.01

(0.0%)

Revenue Summary of Alterity Therapeutics Limited

  • Alterity Therapeutics Limited's latest annual revenue in 2024 was 4.01 Million AUD , up 2.63% from previous year.
  • Alterity Therapeutics Limited's latest quarterly revenue in 2024 FY was - AUD , down -100.0% from previous quarter.
  • Alterity Therapeutics Limited reported a annual revenue of 3.91 Million AUD in annual revenue 2023, down -23.56% from previous year.
  • Alterity Therapeutics Limited reported a annual revenue of 5.12 Million AUD in annual revenue 2022, up 18.06% from previous year.
  • Alterity Therapeutics Limited reported a quarterly revenue of 950.36 Thousand AUD for 2024 Q1, up 24.19% from previous quarter.
  • Alterity Therapeutics Limited reported a quarterly revenue of - AUD for 2024 FY, down -100.0% from previous quarter.

Annual Revenue Chart of Alterity Therapeutics Limited (2024 - 1998)

Historical Annual Revenue of Alterity Therapeutics Limited (2024 - 1998)

Year Revenue Revenue Growth
2024 4.01 Million AUD 2.63%
2023 3.91 Million AUD -23.56%
2022 5.12 Million AUD 18.06%
2021 4.33 Million AUD 0.0%
2020 - AUD -100.0%
2019 108.53 Thousand AUD -46.05%
2018 201.17 Thousand AUD 51.95%
2017 132.39 Thousand AUD -7.19%
2016 142.65 Thousand AUD -19.33%
2015 176.84 Thousand AUD -51.39%
2014 363.77 Thousand AUD 141.12%
2013 150.86 Thousand AUD -19.18%
2012 186.66 Thousand AUD 19.55%
2011 156.13 Thousand AUD -27.38%
2010 215 Thousand AUD -49.79%
2009 428.19 Thousand AUD -12.97%
2008 491.99 Thousand AUD -2.97%
2007 507.04 Thousand AUD -33.5%
2006 762.48 Thousand AUD -71.14%
2005 2.64 Million AUD 14.53%
2004 2.3 Million AUD 27.39%
2003 1.81 Million AUD 127.98%
2002 794.39 Thousand AUD 53.9%
2001 516.18 Thousand AUD 555.4%
2000 78.75 Thousand AUD 0.0%
1999 - AUD 0.0%
1998 - AUD 0.0%

Peer Revenue Comparison of Alterity Therapeutics Limited

Name Revenue Revenue Difference
Evofem Biosciences, Inc. 18.21 Million USD 77.938%
Arch Therapeutics, Inc. 75.72 Thousand USD -5207.809%
CSL Limited 14.69 Billion USD 99.973%
Santhera Pharmaceuticals Holding AG 122.95 Million USD 96.731%
Regen BioPharma, Inc. 236.56 Thousand USD -1599.055%
BioStem Technologies, Inc. 16.68 Million USD 75.911%
Capstone Therapeutics Corp. 48.35 Million USD 91.688%
Qrons Inc. - USD -Infinity%
Nascent Biotech, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 1.93 Million USD -108.038%
Oncotelic Therapeutics, Inc. 70 Thousand USD -5641.836%
Skye Bioscience, Inc. - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. 658.5 Thousand USD -510.37%
Burzynski Research Institute, Inc. - USD -Infinity%
Genscript Biotech Corporation 839.52 Million USD 99.521%
Neon Bloom, Inc. - USD -Infinity%
Adynxx, Inc. - USD -Infinity%
Eiger BioPharmaceuticals, Inc. 15.77 Million USD 74.518%
Nanobac Pharmaceuticals, Incorporated 17.62 Thousand USD -22709.631%
Institute of Biomedical Research Corp. - USD -Infinity%
SQZ Biotechnologies Company 21.47 Million USD 81.287%
Intellipharmaceutics International Inc. 65.72 Thousand USD -6015.027%
Propanc Biopharma, Inc. - USD -Infinity%
Mesoblast Limited 5.9 Million USD 31.9%
Marizyme, Inc. 645.81 Thousand USD -522.363%
Genus plc 668.8 Million USD 99.399%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
Pharming Group N.V. 245.31 Million USD 98.362%
Therapeutic Solutions International, Inc. 98.99 Thousand USD -3960.13%
CNBX Pharmaceuticals Inc. 410.16 Thousand USD -879.919%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 76.76 Thousand USD -5136.103%
IMV Inc. - USD -Infinity%
AXIM Biotechnologies, Inc. 39.51 Thousand USD -10070.77%
MultiCell Technologies, Inc. 49.32 USD -8149301.865%
ONE Bio Corp. 52.29 Million USD 92.314%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 49.72 Million USD 91.916%
Arno Therapeutics, Inc. - USD -Infinity%
EV Biologics, Inc. 48.9 Thousand USD -8119.397%
Q BioMed Inc. 284.35 Thousand USD -1313.489%
Emmaus Life Sciences, Inc. 29.59 Million USD 86.42%
Mosaic ImmunoEngineering Inc. - USD -Infinity%
Biomind Labs Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 145.09 Million USD 97.23%
Provectus Biopharmaceuticals, Inc. 557.71 Thousand USD -620.677%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
GlobeStar Therapeutics Corporation - USD -Infinity%
THC Farmaceuticals, Inc. - USD -Infinity%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. - USD -Infinity%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Halberd Corporation 999.00 USD -402230.831%
Enzolytics Inc. 52.79 Thousand USD -7512.859%
Agentix Corp. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Nuo Therapeutics, Inc. 608.52 Thousand USD -560.496%
MetaStat, Inc. - USD -Infinity%
argenx SE 1.22 Billion USD 99.672%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. 140.24 Thousand USD -2765.964%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. 617.38 Thousand USD -551.019%
Zenith Capital Corp. - USD -Infinity%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. - USD -Infinity%
WPD Pharmaceuticals Inc. - USD -Infinity%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Kadimastem Ltd - USD -Infinity%
Helix BioMedix, Inc. 997.72 Thousand USD -302.845%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
Regen BioPharma, Inc. 236.56 Thousand USD -1599.055%
NovAccess Global Inc. - USD -Infinity%
Affymax, Inc. 1.36 Million USD -193.593%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
CytoDyn Inc. - USD -Infinity%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 473.73 Thousand USD -748.434%
SYBLEU INC 11.69 Thousand USD -34264.612%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. - USD -Infinity%
International Stem Cell Corporation 7.78 Million USD 48.398%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 13 Thousand USD -30817.577%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. - USD -Infinity%
Neutra Corp. 39.53 Thousand USD -10066.654%
Windtree Therapeutics, Inc. - USD -Infinity%
PureTech Health plc 3.33 Million USD -20.699%
Coeptis Therapeutics, Inc. - USD -Infinity%
IXICO plc 6.66 Million USD 39.696%
IntelGenx Technologies Corp. 1.03 Million USD -286.842%
Gelesis Holdings, Inc. 25.76 Million USD 84.401%
CSL Limited 14.8 Billion USD 99.973%
Cellectis S.A. 755 Thousand USD -432.356%